Article Information
History
- May 11, 2022.
Article Versions
- You are currently viewing Version 1 of this article (May 11, 2022 - 16:10).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Lucía Ramos-Alonso1,†,
- Petter Holland§,†,
- Stéphanie Le Gras2,
- Xu Zhao1,
- Bernard Jost2,
- Magnar Bjørås3,4,
- Yves Barral5,*,
- Jorrit M. Enserink1,6,7,* and
- Pierre Chymkowitch1,*
- 1Department of Biosciences, Faculty of Mathematics and Natural Sciences, University of Oslo, 0316 Oslo, Norway
- 2Institut de Génétique et de Biologie Moléculaire et Cellulaire, CNRS UMR7104, Inserm U1258, Université de Strasbourg, Illkirch, France
- 3Department of Microbiology, Oslo University Hospital and University of Oslo, 0372 Oslo, Norway
- 4Department of Clinical and Molecular Medicine, NTNU; Trondheim, Norway
- 5Institute of Biochemistry, Biology Department, ETH Zurich, 8093 Zurich, Switzerland
- 6Department of Molecular Cell Biology, Institute for Cancer Research, Oslo University Hospital, 0372 Oslo, Norway
- 7Centre for Cancer Cell Reprogramming, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, 0318 Oslo, Norway
- ↵*Correspondence: pierre.chymkowitch{at}ibv.uio.no; j.m.enserink{at}ibv.uio.no; yves.barral{at}bc.biol.ethz.ch
↵† Equal contribution